Clinical Determinants, Patterns, and Outcomes of Antipsychotic Medication Prescribing in the Treatment of Schizophrenia and Schizoaffective Disorder: A Naturalistic Cohort Study

被引：0
|
作者：
Groenendaal, Emily [1 ]
Lynch, Sean [2 ]
Dornbush, Rhea [1 ]
Klepacz, Lidia [1 ]
Ferrando, Stephen [1 ]
机构：
[1] New York Med Coll, Valhalla, NY USA
[2] Mt Sinai Beth Israel, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001487
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [31] CEREBROSPINAL-FLUID SOMATOSTATIN CONCENTRATIONS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER - THE EFFECTS OF ANTIPSYCHOTIC TREATMENT
    SHARMA, RP
    BISSETTE, G
    JANICAK, P
    DAVIS, JM
    NEMEROFF, CB
    SCHIZOPHRENIA RESEARCH, 1994, 13 (02) : 173 - 177
  • [32] Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder
    Dunayevich, Eduardo
    Ascher-Svanum, Haya
    Zhao, Fangyi
    Jacobson, Jennie G.
    Phillips, Glenn A.
    Dellva, Mary Anne
    Green, Alan I.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (08) : 1163 - 1171
  • [33] The implications of antipsychotic treatment patterns on health outcomes in schizophrenia
    Engelhart, L
    Janagap, C
    White, R
    Rothman, M
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 31S - 31S
  • [34] Bone density in chronic schizophrenia and schizoaffective disorder with long-term antipsychotic treatment
    Lee, T. Y.
    Chung, M. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 99 - 99
  • [35] Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder
    Howes, Oliver D.
    Wheeler, Michael J.
    Pilowsky, Lyn S.
    Landau, Sabine
    Murray, Robin M.
    Smith, Shubulade
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (03) : 361 - 367
  • [36] Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
    Elie, D.
    Poirier, M.
    Chianetta, J. M.
    Durand, M.
    Gregoire, C. A.
    Grignon, S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1037 - 1044
  • [37] SUBJECTIVE EXPERIENCE MEASUREMENT IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER USING THE NOVEL ANTIPSYCHOTIC MEDICATION EXPERIENCE SCALE (NAMES)
    Wirshing, Donna A.
    Rosen, J.
    Pierre, J. M.
    Erickson, Z. D.
    Guzik, L. H.
    Mena, S. J.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 36 - 36
  • [38] Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia
    Xiang Yu-Tao
    Weng Yong-Zhen
    Leung Chi-Ming
    Tang Wai-Kwong
    Ungavri, Gabor Sandor
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (03) : 173 - 180
  • [39] Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response
    Lindenmayer, Jean-Pierre
    Liu-Seifert, Hong
    Kulkarni, Pandurang M.
    Kinon, Bruce J.
    Stauffer, Virginia
    Edwards, Sara E.
    Chen, Lei
    Adams, David H.
    Ascher-Svanum, Haya
    Buckley, Peter F.
    Citrome, Leslie
    Volavka, Jan
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (07) : 990 - 996
  • [40] Are Patients With Schizophrenia Better Off With Lifetime Antipsychotic Medication? Replication of a Naturalistic, Long-Term, Follow-Up Study of Antipsychotic Treatment
    Glick, Ira D.
    Zamora, Daisy
    Davis, John M.
    Suryadevara, Uma
    Goldenson, Andrea
    Kamis, Danielle
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (02) : 145 - 148
12345